Select Page

Alicia Henn

Alicia Henn has been the Chief Scientific Officer of BioSpherix, Ltd since 2013. Previously, she was a researcher at the Center for Biodefense Immune Modeling in Rochester, NY. Alicia obtained her PhD in molecular pharmacology and cancer therapeutics from Roswell Park Cancer Institute in Buffalo, NY and her MBA from the Simon School at University of Rochester in Rochester, NY.

Cytocentric Visionaries Ian Mudway p1

Cytocentric Visionaries: Ian Mudway, King's College, UK Part One: What Are the Fundamental Things That We Absolutely Have To Get Right? Ian Mudway is a Lecturer in Respiratory Toxicology at King’s College in London. He has been active in air...

read more

Cord Blood HSC and Physiologic Oxygen

Mini-Review: Cord Blood HSC and Physiologic Oxygen At what oxygen level should I culture my umbilical cord-derived hematopoietic stem cells? It’s not a question you will hear on Jeopardy, but it is a critically important question for research...

read more

Cytocentric Visionaries Michael Gilkey p3

Cytocentric Visionaries: Michael Gilkey, CEO Trailhead Biosystems Part Three: Let the Cells Lead the Way through the Matrix and Don’t Be Afraid of Change. In part 2, we sit with Trailhead Systems CEO, Michael Gilkey, to discuss using the Xvivo...

read more

Cytocentric Visionaries Michael Gilkey p2

Cytocentric Visionaries: Michael Gilkey, CEO Trailhead Biosystems Part Two: How to Get that Just-Right Cell in the Middle Alicia Henn, Chief Scientific Officer, BioSpherix IIn the first part of our interview with Michael Gilkey, CEO of...

read more

Cytocentric Visionaries Michael Gilkey p1

Cytocentric Visionaries: Michael Gilkey, CEO Trailhead Biosystems Part One: Optimizing Cell Media in 12 Dimensions: You Can’t Do This by Hand Alicia Henn, Chief Scientific Officer, BioSpherix In addition to being CEO of the Ohio...

read more

Cytocentric Visionaries Donald Phinney p3

Cytocentric Visionaries: Donald Phinney Part 3: The Cell Cycle Is the Redox Cycle, and All Clinical MSC are Stressed In Part Two, Chief Scientific Officer Alicia Henn talked with Dr. Phinney about MSC, the exosomes that they produce and...

read more

Cytocentric Visionaries Donald Phinney p2

Cytocentric Visionaries: Donald Phinney Part Two: MSC vs Exosomes and Therapies In Part One, Chief Scientific Officer Alicia Henn talks with Dr. Phinney about his publication in Nature Communications, ”Mesenchymal stem cells use...

read more

Cytocentric Visionaries Donald Phinney p1

Cytocentric Visionaries: Donald Phinney, Chair Department of Molecular Therapeutics, The Scripps Research Institute Part One: Mesenchymal Stem Cells, as Healers, Aren’t So Selfless Chair of the Molecular Therapeutics Department at Scripps, Dr....

read more

Gas Control in Semi-sealed Chambers

Gas Control in Semi-sealed Chambers Dalton in the Incubator We are all familiar with how CO2 is infused into cell culture incubators to raise CO2 to physiologic levels and keep carbonic acid based media in the proper pH range for...

read more